The bacterial effector Cif interferes with SCF ubiquitin ligase function by inhibiting deneddylation of Cullin1

Biochemical and Biophysical Research Communications

Volumn 401, Issue 2, 2010, Pages 268-274

  Morikawa, Hanako ^a   Kim, Minsoo ^b   Mimuro, Hitomi ^a   Punginelli, Claire ^a   Koyama, Tomohiro ^c   Nagai, Shinya ^c   Miyawaki, Atsushi ^d   Iwai, Kazuhiro ^e   Sasakawa, Chihiro ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b THE UNIVERSITY OF TOKYO   (Japan)

^c NIPPON INSTITUTE FOR BIOLOGICAL SCIENCE   (Japan)

^d RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bacterial infection; Cell cycle; Effector; NEDD8; Ubiquitin

Indexed keywords

BACTERIAL PROTEIN; CULLIN; CULLIN 1; CYCLE INHIBITING FACTOR; CYCLIN D1; F BOX PROTEIN; NEDD8 PROTEIN; PROTEIN P27; REPLICATION LICENSING FACTOR CDT1; S PHASE KINASE ASSOCIATED PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; ENTEROPATHOGENIC ESCHERICHIA COLI; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

CELL LINE; CULLIN PROTEINS; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; G1 PHASE; HELA CELLS; HUMANS; SKP CULLIN F-BOX PROTEIN LIGASES; UBIQUITINS;

BACTERIA (MICROORGANISMS); BURKHOLDERIA; ESCHERICHIA COLI; PHOTORHABDUS LUMINESCENS; YERSINIA PSEUDOTUBERCULOSIS;

EID: 77957790866     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.048     Document Type: Article

References (20)

1. Kim M., Ashida H., Ogawa M., et al. Bacterial interactions with the host epithelium. Cell Host Microbe 2010, 8:20-35.
2. Nougayrede J.P., Taieb F., De Rycke J., et al. Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol. 2005, 13:103-110.
3. Kaper J.B., Nataro J.P., Mobley H.L. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2004, 2:123-140.
4. Marches O., Ledger T.N., Boury M., et al. Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol. Microbiol. 2003, 50:1553-1567.
5. Samba-Louaka A., Nougayrede J.P., Watrin C., et al. Bacterial cyclomodulin Cif blocks the host cell cycle by stabilizing the cyclin-dependent kinase inhibitors p21 and p27. Cell. Microbiol. 2008, 10:2496-2508.
6. Samba-Louaka A., Nougayrede J.P., Watrin C., et al. The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells. Infect. Immun. 2009, 77:5471-5477.
7. Yao Q., Cui J., Zhu Y., et al. A bacterial type III effector family uses the papain-like hydrolytic activity to arrest the host cell cycle. Proc. Natl. Acad. Sci. U.S.A 2009, 106:3716-3721.
8. Crow A., Race P.R., Jubelin G., et al. Crystal structures of Cif from bacterial pathogens Photorhabdus luminescens and Burkholderia pseudomallei. PLoS ONE 2009, 4:e5582.
9. Hsu Y., Jubelin G., Taieb F., et al. Structure of the cyclomodulin Cif from pathogenic Escherichia coli. J. Mol. Biol. 2008, 384:465-477.
10. Nakayama K.I., Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 2006, 6:369-381.
11. Petroski M.D., Deshaies R.J. Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 2005, 6:9-20.
12. Kim M., Tezuka T., Tanaka K., et al. Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation. Oncogene 2004, 23:1645-1655.
13. Miyauchi Y., Kato M., Tokunaga F., et al. The COP9/signalosome increases the efficiency of von Hippel-Lindau protein ubiquitin ligase-mediated hypoxia-inducible factor-alpha ubiquitination. J. Biol. Chem. 2008, 283:16622-16631.
14. Nijman S.M., Luna-Vargas M.P., Velds A., et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005, 123:773-786.
15. Sakaue-Sawano A., Kurokawa H., Morimura T., et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 2008, 132:487-498.
16. Podust V.N., Brownell J.E., Gladysheva T.B., et al. A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination. Proc. Natl. Acad. Sci U.S.A 2000, 97:4579-4584.
17. Tomoda K., Yoneda-Kato N., Fukumoto A., et al. Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J. Biol. Chem. 2004, 279:43013-43018.
18. Soucy T.A., Smith P.G., Milhollen M.A., et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 2009, 458:732-736.
19. Chen Y., Yang Z., Meng M., et al. Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement. Mol. Cell. 2009, 35:841-855.
20. Leck Y.C., Choo Y.Y., Tan C.Y., et al. Biochemical and cellular effects of inhibiting Nedd8 conjugation. Biochem. Biophys. Res. Commun. 2010, 398:588-593.